Compounds > 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane
Page last updated: 2024-09-05

1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and propafenone

1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane has been researched along with propafenone in 2 studies

Compound Research Comparison

Studies
(1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane)		Trials
(1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane)		Recent Studies (post-2010)
(1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane)		Studies
(propafenone)		Trials
(propafenone)		Recent Studies (post-2010) (propafenone)
36191,471268239

Protein Interaction Comparison

ProteinTaxonomy1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane (IC50)propafenone (IC50)
Potassium channel subfamily K member 3Homo sapiens (human)5.1
ATP-binding cassette sub-family C member 9Homo sapiens (human)2.2
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.384
Potassium channel subfamily K member 2Homo sapiens (human)7.6
Cytochrome P450 1A2Homo sapiens (human)3.292
Beta-2 adrenergic receptorHomo sapiens (human)0.052
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)3.016
ATP-dependent translocase ABCB1Homo sapiens (human)0.3311
Beta-1 adrenergic receptorHomo sapiens (human)0.354
Cytochrome P450 2D6Homo sapiens (human)4.6034
Beta-3 adrenergic receptorHomo sapiens (human)0.424
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)1.637
Sodium-dependent noradrenaline transporter Homo sapiens (human)3.016
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.654
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.384
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)1.637
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.092
5-hydroxytryptamine receptor 6Homo sapiens (human)1.863
Sodium-dependent dopamine transporter Homo sapiens (human)1.868
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.3733
Sodium channel protein type 5 subunit alphaHomo sapiens (human)2.245
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)2.2
Sigma non-opioid intracellular receptor 1Homo sapiens (human)2.61

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD1
Chen, H; Gao, X; He, W; Hu, J; Ren, P; Zhu, Y1

Other Studies

2 other study(ies) available for 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and propafenone

ArticleYear
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
    Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18

    Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2004
DDPH, a novel antihypertensive agent, is a potential dual inhibitor of hepatic CYP2D and CYP3A.
    Chemico-biological interactions, 2016, Mar-05, Volume: 247

    Topics: Animals; Antihypertensive Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Liver; Male; Phenethylamines; Propafenone; Rats; Rats, Sprague-Dawley

2016